ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA
Clinical trials for ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test new drug duo in fight against tough nasal cancers
Disease control OngoingThis early-stage trial is testing the safety and best dose of a two-drug combination (vorinostat and azacitidine) for patients with advanced nasal and throat cancers that have returned or spread. The study aims to see if these drugs, which work differently to stop cancer cell gro…
Matched conditions: ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New strategy aims to tame dangerous virus after cancer transplant
Disease control OngoingThis study is testing a personalized plan to manage cytomegalovirus (CMV), a common and potentially serious infection, in patients who have received a donor stem cell transplant for blood cancers or disorders. The plan involves closely monitoring the virus level and the patient's…
Matched conditions: ADULT NASAL TYPE EXTRANODAL NK/T-CELL LYMPHOMA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC